Detalles de la búsqueda
1.
Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial).
J Antimicrob Chemother
; 76(5): 1286-1293, 2021 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33624081
2.
Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.
J Antimicrob Chemother
; 70(5): 1517-21, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25583749
3.
New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon.
Bull World Health Organ
; 93(8): 521-8, 2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26478609
4.
HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatment.
AIDS Res Ther
; 12: 36, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26566389
5.
Barriers to the implementation of mobile phone reminders in pediatric HIV care: a pre-trial analysis of the Cameroonian MORE CARE study.
BMC Health Serv Res
; 14: 523, 2014 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25344732
6.
Prevalence of prolonged otitis media with effusion among 2 to 3 years old Cameroonian children in the era of 13-valent pneumococcal conjugate vaccines.
IJID Reg
; 10: 240-247, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38532743
7.
Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
J Antimicrob Chemother
; 68(6): 1388-99, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23391713
8.
Tuberculous meningitis: presentation, diagnosis and outcome in hiv-infected patients at the douala general hospital, cameroon: a cross sectional study.
AIDS Res Ther
; 10(1): 16, 2013 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23758832
9.
Antimicrobial stewardship in the era of the COVID-19 pandemic: A systematic review protocol on the opportunities and challenges for Sub-Saharan Africa.
Medicine (Baltimore)
; 102(19): e33697, 2023 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171319
10.
APOL1 Renal Risk Variants and Kidney Function in HIV-1-Infected People From Sub-Saharan Africa.
Kidney Int Rep
; 7(3): 483-493, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35257061
11.
Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children Ë5 years in Cameroon, 2011-2018.
PLoS One
; 16(4): e0250010, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33857235
12.
Prevalence of unsafe sex with one's steady partner either HIV-negative or of unknown HIV status and associated determinants in Cameroon (EVAL ANRS12-116 survey).
Sex Transm Infect
; 86(2): 148-54, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19837727
13.
WHO clinical criteria-based initiation of antiretroviral therapy: lessons from rural district hospitals in Cameroon with regard to 2009 revised WHO recommendations.
Trop Med Int Health
; 15(5): 580-3, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20214755
14.
Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116).
AIDS Care
; 22(4): 441-51, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20140791
15.
Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
BMC Public Health
; 10: 105, 2010 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20193053
16.
Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction.
Int J Infect Dis
; 98: 113-120, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32562849
17.
Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.
Clin Infect Dis
; 48(9): 1318-22, 2009 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19320592
18.
Human immunodeficiency virus infection and associated factors among specific population subgroups in Cameroon.
AIDS Behav
; 13(2): 277-87, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17694430
19.
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
Lancet Infect Dis
; 19(4): e143-e147, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30344084
20.
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
AIDS Res Hum Retroviruses
; 24(3): 393-9, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18327976